Home
About
Overview
Sharing Data
ORCID
Help
History (84)
Effect of Aficamten on Health Status?Outcomes in Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCM.
Effect of Aficamten on Cardiac Structure?and Function in Obstructive Hypertrophic Cardiomyopathy: SEQUOIA-HCM CMR Substudy.
Ventricular Septal Myectomy Decreases Long-Term Risk for Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy.
Safety, Side Effects and Relative Efficacy of Medications for Rhythm Control of Atrial Fibrillation in Hypertrophic Cardiomyopathy.
PRKAG2 Glycogen Storage Disease Cardiomyopathy: Out of the Darkness and Into the Light.
See All 84 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
PRKAG2 Glycogen Storage Disease Cardiomyopathy: Out of the Darkness and Into the Light.
Maron BJ, Maron MS. PRKAG2 Glycogen Storage Disease Cardiomyopathy: Out of the Darkness and Into the Light. J Am Coll Cardiol. 2020 07 14; 76(2):198-200.
View in:
PubMed
subject areas
AMP-Activated Protein Kinases
Cardiomyopathies
Glycogen Storage Disease
Humans
authors with profiles
Martin S Maron MD, MSPH
Barry J Maron MD